A recently developed medication encourages people with cocaine use disorder to reduce their intake of the stimulant – a step ...

This development comes at a time when pharmaceutical firms are discontinuing discovery efforts in next-generation COVID-19 ...

A new drug tested in a phase 3 trial showed significant improvement in patients with treatment-resistant ovarian cancer.

Discover how the experimental drug lepodisiran dramatically lowers lipoprotein(a) levels, potentially transforming treatment ...

A single dose of an experimental drug dramatically reduced levels of a deadly form of cholesterol, often thought to be ...

This is a major source of cardiovascular morbidity and mortality. We have never been able to treat lipoprotein(a) until now.” ...

The Eli Lilly drug caused a major drop in the blood levels of Lp(a), but further research is needed to show that it will ...

For the study, the researchers gave the study participants an experimental anti-amyloid drug. They found that 22 participants ...

Eli Lilly’s experimental drug, lepodisiran, reduces lipoprotein(a) (Lp[a]) levels by an average of 93.9 per cent in a ...

In an exclusive interview with NBC News, President Donald Trump said there were methods that would allow him to seek a third ...